These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 39002007
1. Anti-Carbamylated Protein Antibodies in ACPA-Negative and ACPA-Positive Patients with Rheumatoid Arthritis. Dibrov DA, Avdeeva AS, Diatroptov ME, Nasonov EL. Dokl Biochem Biophys; 2024 Aug; 517(1):235-242. PubMed ID: 39002007 [Abstract] [Full Text] [Related]
2. Specific Association of HLA-DRB1*03 With Anti-Carbamylated Protein Antibodies in Patients With Rheumatoid Arthritis. Regueiro C, Rodriguez-Rodriguez L, Triguero-Martinez A, Nuño L, Castaño-Nuñez AL, Villalva A, Perez-Pampin E, Lopez-Golan Y, Abasolo L, Ortiz AM, Herranz E, Pascual-Salcedo D, Martínez-Feito A, Boveda MD, Gomez-Reino JJ, Martín J, Gonzalez-Escribano MF, Fernandez-Gutierrez B, Balsa A, Gonzalez-Alvaro I, Gonzalez A. Arthritis Rheumatol; 2019 Mar; 71(3):331-339. PubMed ID: 30277011 [Abstract] [Full Text] [Related]
3. Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases. Pecani A, Alessandri C, Spinelli FR, Priori R, Riccieri V, Di Franco M, Ceccarelli F, Colasanti T, Pendolino M, Mancini R, Truglia S, Barbati C, Vomero M, Sabatinelli D, Morello F, Valesini G, Conti F. Arthritis Res Ther; 2016 Nov 25; 18(1):276. PubMed ID: 27887639 [Abstract] [Full Text] [Related]
4. Diagnostic and prognostic value of anti-CarP antibodies in a sample of Egyptian rheumatoid arthritis patients. Elsayed SA, Esmail MA, Ali RM, Mohafez OM. Clin Rheumatol; 2019 Oct 25; 38(10):2683-2689. PubMed ID: 31161487 [Abstract] [Full Text] [Related]
5. [Application value of anti-carbamylated protein antibody in the diagnosis of rheumatoid arthritis]. Li Z, Luo C, Wu L, Wu X, Meng X, Chen X, Shi Y, Zhong Y. Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Aug 18; 56(4):729-734. PubMed ID: 39041572 [Abstract] [Full Text] [Related]
6. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients. van Delft MAM, Verheul MK, Burgers LE, Derksen VFAM, van der Helm-van Mil AHM, van der Woude D, Huizinga TWJ, Toes REM, Trouw LA. Arthritis Res Ther; 2017 Aug 15; 19(1):190. PubMed ID: 28810902 [Abstract] [Full Text] [Related]
7. Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis. Lamacchia C, Courvoisier DS, Jarlborg M, Bas S, Roux-Lombard P, Möller B, Ciurea A, Finckh A, Bentow C, Martinez-Prat L, Mahler M, Gabay C, Nissen MJ, SCQM Rheumatologists. Rheumatology (Oxford); 2021 Oct 02; 60(10):4598-4608. PubMed ID: 33502443 [Abstract] [Full Text] [Related]
8. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example. Boeters DM, Trouw LA, van der Helm-van Mil AHM, van Steenbergen HW. Arthritis Res Ther; 2018 May 03; 20(1):94. PubMed ID: 29724250 [Abstract] [Full Text] [Related]
9. Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort. Truchetet ME, Dublanc S, Barnetche T, Vittecoq O, Mariette X, Richez C, Blanco P, Mahler M, Contin-Bordes C, Schaeverbeke T, Fédération Hospitalo-Universitaire ACRONIM. Arthritis Rheumatol; 2017 Dec 03; 69(12):2292-2302. PubMed ID: 28853240 [Abstract] [Full Text] [Related]
10. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity. Reed E, Hedström AK, Hansson M, Mathsson-Alm L, Brynedal B, Saevarsdottir S, Cornillet M, Jakobsson PJ, Holmdahl R, Skriner K, Serre G, Alfredsson L, Rönnelid J, Lundberg K. Arthritis Res Ther; 2020 Jul 16; 22(1):170. PubMed ID: 32678001 [Abstract] [Full Text] [Related]
11. Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases. Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K. J Rheumatol; 2017 Sep 16; 44(9):1384-1388. PubMed ID: 28507178 [Abstract] [Full Text] [Related]
12. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Yee A, Webb T, Seaman A, Infantino M, Meacci F, Manfredi M, Benucci M, Lakos G, Favalli E, Schioppo T, Meroni PL, Mahler M. Immunol Res; 2015 Feb 16; 61(1-2):24-30. PubMed ID: 25391608 [Abstract] [Full Text] [Related]
13. Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases. Sidiras P, Spruyt D, Gangji V, Imbault V, Sokolova T, Durez P, Communi D, Rasschaert J, Badot V. Scand J Rheumatol; 2021 Mar 16; 50(2):118-123. PubMed ID: 33025839 [Abstract] [Full Text] [Related]
14. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor. Ajeganova S, van Steenbergen HW, Verheul MK, Forslind K, Hafström I, Toes RE, Huizinga TW, Svensson B, Trouw LA, van der Helm-van Mil AH. Ann Rheum Dis; 2017 Jan 16; 76(1):112-118. PubMed ID: 27117699 [Abstract] [Full Text] [Related]
15. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls. Koppejan H, Trouw LA, Sokolove J, Lahey LJ, Huizinga TJ, Smolik IA, Robinson DB, El-Gabalawy HS, Toes RE, Hitchon CA. Arthritis Rheumatol; 2016 Sep 16; 68(9):2090-8. PubMed ID: 26946484 [Abstract] [Full Text] [Related]
16. Anti-Carbamylated Fibrinogen Antibodies Might Be Associated With a Specific Rheumatoid Phenotype and Include a Subset Recognizing In Vivo Epitopes of Its γ Chain One of Which Is Not Cross Reactive With Anti-Citrullinated Protein Antibodies. Brevet P, Lattard C, Guillou C, Rottenberg P, Fardellone P, Le-Loët X, Lequerré T, Cosette P, Boyer O, Fréret M, Vittecoq O. Front Immunol; 2021 Sep 16; 12():733511. PubMed ID: 34691039 [Abstract] [Full Text] [Related]
17. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Shi J, Knevel R, Suwannalai P, van der Linden MP, Janssen GM, van Veelen PA, Levarht NE, van der Helm-van Mil AH, Cerami A, Huizinga TW, Toes RE, Trouw LA. Proc Natl Acad Sci U S A; 2011 Oct 18; 108(42):17372-7. PubMed ID: 21987802 [Abstract] [Full Text] [Related]
18. Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis? Ponchel F, van Delft MAM, Xie X, Burska AN, Duquenne L, Trouw LA, Emery P. Clin Exp Rheumatol; 2021 Oct 18; 39(1):146-150. PubMed ID: 32662401 [Abstract] [Full Text] [Related]
19. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Jiang X, Trouw LA, van Wesemael TJ, Shi J, Bengtsson C, Källberg H, Malmström V, Israelsson L, Hreggvidsdottir H, Verduijn W, Klareskog L, Alfredsson L, Huizinga TW, Toes RE, Lundberg K, van der Woude D. Ann Rheum Dis; 2014 Oct 18; 73(10):1761-8. PubMed ID: 24812286 [Abstract] [Full Text] [Related]
20. Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients. Martínez G, Gómez JA, Bang H, Martínez-Gamboa L, Roggenbuck D, Burmester GR, Torres B, Prada D, Feist E. Rheumatol Int; 2016 Jun 18; 36(6):781-91. PubMed ID: 27038800 [Abstract] [Full Text] [Related] Page: [Next] [New Search]